Myiasis (Intestinal fly larvae - Eristalis)

1. Executive Overview: Understanding Intestinal Myiasis

Intestinal myiasis is a rare but clinically significant parasitic infestation where the larvae of dipterous flies (commonly Eristalis tenax, the drone fly) colonize the gastrointestinal tract of humans. Classified under ICD-10 code B87.8, this condition occurs when humans accidentally ingest food or water contaminated with fly eggs or larvae.

While often considered an accidental or "pseudomyiasis" event, the presence of these larvae can lead to significant gastrointestinal distress and systemic symptoms. Because the larvae are not obligate human parasites, they cannot complete their life cycle within the human host, yet their presence can cause localized tissue irritation, mechanical obstruction, and secondary inflammatory responses. This guide provides an authoritative overview for patients seeking clarity on the diagnosis, clinical management, and long-term prognosis of Eristalis intestinal myiasis.

2. Pathophysiology, Etiology, and Risk Factors

Etiology and Transmission

The primary causative agent in intestinal myiasis is the larva of the Eristalis tenax (drone fly). These flies are attracted to decaying organic matter, sewage, and stagnant water. Transmission occurs via the fecal-oral route, specifically through:
* Contaminated Water: Ingestion of stagnant or untreated water sources.
* Food Contamination: Consuming raw vegetables or fruits that have been in contact with contaminated soil or water containing fly eggs.
* Poor Sanitation: Living environments with inadequate sewage management.

Pathophysiology

Once ingested, the larvae—which are highly resistant to gastric acid—pass through the stomach into the small and large intestines. They do not typically penetrate the intestinal wall; instead, they attach to the mucosal lining using their posterior breathing tubes (siphons) or mouth hooks. The irritation of the intestinal mucosa leads to increased mucus production, localized inflammation, and altered motility.

Risk Factors

The condition is more prevalent in regions with poor sanitation and in specific high-risk groups:
| Risk Factor | Description |
| :--- | :--- |
| Poor Hygiene | Inadequate handwashing and food preparation standards. |
| Geography | Tropical and subtropical regions with high fly density. |
| Age | Pediatric populations are at higher risk due to hand-to-mouth behaviors. |
| Host Immunity | Individuals with achlorhydria (low stomach acid) may be more susceptible as gastric acid is a primary defense against larvae. |

3. Signs, Symptoms, and Clinical Presentation

The clinical manifestation of intestinal myiasis is often nonspecific, which frequently leads to misdiagnosis as common gastroenteritis or irritable bowel syndrome (IBS).

Common Clinical Presentations

1. Abdominal Pain: Often described as cramping or colicky pain in the epigastric or periumbilical regions.
2. Gastrointestinal Distress: Chronic diarrhea, nausea, and occasional vomiting.
3. Flatulence and Bloating: Secondary to altered digestive processes and larval presence.
4. Visible Larvae: The most pathognomonic sign is the passage of live or dead larvae in the stool.
5. Pruritus Ani: Intense itching in the perianal area, particularly if larvae are exiting the rectum.

Differential Diagnosis

Clinicians must differentiate intestinal myiasis from:
* Helminthic infections (Ascaris lumbricoides, Enterobius vermicularis).
* Bacterial gastroenteritis (Salmonella, Shigella, Campylobacter).
* Inflammatory Bowel Disease (IBD).
* Functional GI disorders.

4. Standard Diagnostic Evaluation & Workup

Diagnosis is rarely suspected initially. It is usually confirmed only after the patient reports the observation of "moving objects" in their stool.

Diagnostic Steps

• Clinical History: Detailed travel history, dietary habits, and sanitation status.
• Stool Microscopy (Gold Standard): The definitive diagnosis is the microscopic identification of the larvae. Samples should be collected in a clean container and examined by a parasitologist to identify the morphological characteristics of Eristalis larvae (e.g., the presence of a telescopic posterior respiratory siphon).
• Endoscopy (Colonoscopy/EGD): In cases of persistent, unexplained abdominal symptoms, endoscopy may be performed. It allows for direct visualization of the larvae attached to the intestinal mucosa and enables the removal of the specimen for biopsy and identification.
• Imaging: Abdominal X-rays or CT scans are generally not diagnostic for the larvae themselves but are used to rule out secondary complications like bowel obstruction or perforation.

5. Therapeutic Interventions

Treatment is typically straightforward, as the larvae cannot survive permanently in the human host.

Pharmacotherapy

• Antiparasitic Agents: While there is no standard "cure" protocol, clinicians often prescribe Ivermectin or Albendazole to assist in the expulsion of the larvae and to treat potential co-infections.
• Symptomatic Relief: Antispasmodics for pain and probiotics to restore gut flora following the infestation.

Surgical/Mechanical Intervention

• Endoscopic Removal: If larvae are visualized during a colonoscopy, they are mechanically removed using biopsy forceps. This is the most effective way to provide immediate relief and definitive identification.

Lifestyle and Prevention

• Water Safety: Boil water before consumption in endemic regions.
• Hygiene: Rigorous hand hygiene, especially before preparing or consuming food.
• Food Safety: Thoroughly wash raw produce and protect food from fly contact.

6. Frequently Asked Questions (FAQ)

1. Is intestinal myiasis contagious?
No, it is not transmitted from person to person. It is acquired through the ingestion of eggs or larvae from contaminated food or water.

2. Can these larvae live in my stomach forever?
No. Humans are "accidental hosts." The larvae cannot complete their life cycle in the human gut and will eventually be expelled or die.

3. What does Eristalis larva look like in the stool?
They are often described as "rat-tailed maggots" due to their long, telescopic respiratory tail. They appear as off-white, segmented worm-like organisms.

4. Is this condition life-threatening?
It is rarely life-threatening. However, if left untreated, it can cause chronic inflammation, anemia, or secondary bacterial infections.

5. How do I know if I have myiasis?
The only definitive way to know is to see a doctor and have a stool sample analyzed. If you see moving organisms in your stool, collect a sample in a sterile container and seek medical attention.

6. Does the larva cause internal damage?
Generally, no. They do not burrow deep into the intestinal wall, but they can cause superficial mucosal irritation and inflammation.

7. Is a colonoscopy always necessary?
Not always. A colonoscopy is usually reserved for patients with persistent, severe symptoms that do not resolve with standard antiparasitic treatment.

8. Can I treat this at home with herbal remedies?
No. Self-treatment is not recommended. You must see a healthcare professional to confirm the diagnosis and ensure proper management.

9. Are there long-term complications?
Once the larvae are removed and the infestation is cleared, there are typically no long-term health consequences.

10. How long does the treatment take?
Most cases resolve within a few days to weeks once the source of the infestation is removed and antiparasitic medication (if deemed necessary by your physician) is administered.

7. Prognosis and Long-Term Outlook

The prognosis for patients with Eristalis intestinal myiasis is excellent. Because the condition is an accidental infestation rather than a chronic disease, the removal of the larvae leads to the complete resolution of symptoms. Patients are advised to maintain high standards of food and water hygiene to prevent reinfection. Chronic cases are exceptionally rare and usually indicate a recurring exposure to contaminated environments. If you suspect an infestation, consult your gastroenterologist immediately for a professional evaluation.

Related Clinical Integration

In the clinical management of intestinal myiasis caused by Eristalis larvae, a systematic approach is required to confirm the diagnosis and facilitate parasite clearance. When clinical suspicion arises, a Colonoscopy (Diagnostic/Screening) / تنظير القولون (تشخيصي/فحص) (فحص بالمنظار أو أخذ عينات) is the gold-standard procedure for direct visualization and mechanical removal of the larvae from the intestinal mucosa. This procedure is performed utilizing a high-definition Colonoscope (CF-HQ190L/I - Variable stiffness) / منظار القولون (CF-HQ190L/I - بصلابة متغيرة), which allows for precise navigation and safe extraction of the organisms. Following the removal of the larvae, pharmacological intervention with Albendazole / ألبيندازول 200mg may be indicated as an adjunctive therapy to ensure the eradication of any remaining ova or larvae, thereby preventing potential secondary complications and ensuring complete resolution of the infestation.